Literature DB >> 30983809

Bacteremia caused by Comamonas testosteroni an unusual pathogen.

Shreekant Tiwari1, Monalisah Nanda2.   

Abstract

Comamonas species are rare isolates in microbiology laboratories and have been infrequently reported as an infectious agent in routine clinical practice. They have a wide range of natural habitats including water, soil, and plants as well as from some hospital devices, such as intravenous lines and the reservoir water in the humidifiers of respiratory therapy equipment. Comamonas testosteroni is rarely recognized as a human pathogen. In spite of its uncommon human pathogenesis, there are few reports where it was reported as an aggressive opportunistic pathogen, and that was mostly related to Testosterone species. Herewith, we are reporting this pathogen from the blood of an immunocompetent female. The aim of this case report is to alert clinicians and laboratory physicians for the potential diagnosis and clinical approach of bloodstream infections caused by such unusual pathogens. This is the first documented case of bacteremia caused by C. testosteroni from India.

Entities:  

Keywords:  Bacteremia; Comamonas testosteroni; immunocompetent

Year:  2019        PMID: 30983809      PMCID: PMC6437828          DOI: 10.4103/JLP.JLP_116_18

Source DB:  PubMed          Journal:  J Lab Physicians        ISSN: 0974-2727


Introduction

Comamonas testosteroni is an aerobic Gram-negative bacillus that is oxidase positive, motile, nonspore forming, nonglucose fermenting, and arranged either singly or in pairs.[1] It was formerly known as Pseudomonas testosteroni, and now this bacillus was reclassified by molecular genetics. It was renamed as C. testosteroni as it is known to use testosterone as the sole source of carbon for their growth. Although it has low virulence potency, however, there are few case reports on its involvement in human infections. became clinically important after 1987 when reports began accumulating on human infections such as peritonitis, cellulitis, endocarditis, meningitis, pneumonia, endophthalmitis, and tenosynovitis[2] but cases of bloodstream infections caused by C. testosteroni have been infrequently reported. C. testosteroni is commonly found in soil, water saprophytes, and plants. It has also been detected in the water of in-use hospital oxygen humidifier reservoirs, hemodialysis solutions, urine, mucus, prostate tissue, stool, and respiratory secretions of cystic fibrosis patients.[3] However, it has not been recognized as a component of the endogenous human microflora. The genus Comamonas originally contained following species: Comamonas terrigena, C. testosteroni, Comamonas denitrificans Comamonas nitrativorans, and Comamonas kerstersii. It now contains 17 species, while Comamonas acidovorans has been separated from the genus on the basis of its 16S rRNA gene and is now known as Delftia acidovorans. Although pathogenic potential of C. testosteroni has not been studied well, it is usually considered as a commensals. Around 36 cases have been reported in medical literature concerning C. testosteroni infection so far.[3] Herewith, we are reporting the first documented case of C. testosteroni bloodstream infection from India.

Case Report

A 46-year-old female from rural area admitted to our hospital with chief complains of high-grade fever (103°F), headache, fast breathing, and burning micturition for the past 6 days. On examination, other findings were such as respiratory rate 82/min, bilateral fine crepitation, pulse rate 146/min, and blood pressure 140/90 mmHg. Central nervous system, cardiovascular system, and per abdominal examinations were within normal limit. Other relevant laboratory findings include hemoglobin 10 gm%, total white blood cell count 24,200/cmm, neutrophil 90%, lymphocyte 10%, fasting blood sugar – 88 mg/dl, erythrocyte sedimentation rate 50 mm after 1 h, Na – 123 m. mol/L, K – 4.2 m. mol/L, blood urea – 45 mg/dl, serum creatinine – 1.8 mg/dl, urine routine microscopy shows pus cells 6–10/hpf, albumin-trace, and no parasites. Serological tests such as HBsAg, HIV, HCV, and dengue (NS1Ag, IgM, and IgG) were negative by Enzyme-linked immunosorbent assay. Chest X-ray shows bilateral opacities in lower lobe and ultrasound sonography (USG) abdomen was normal. Blood was collected with complete aseptic precaution in aerobic and anaerobic blood culture bottle (BacT/ALERT/3D; bioMerieux, Marcy l'Etoile, France). The patient was then started empirically with piperacillin + tazobactam and vancomycin. Aerobic blood culture bottle showed a positive sign of growth after 72 h. The broth was then subcultured on 5% sheep blood agar and MacConkey agar. After overnight incubation, MacConkey agar showed nonlactose fermenting colony but colony morphology was better seen after 48 h of aerobic incubation. Colonies were 1–2 mm in diameter, translucent, smooth surface, and nonpigmented [Figure 1]. Blood agar plate showed similar colony morphology and nonpigmented. Gram-stain was done from both the culture plates, and it was Gram-negative bacilli. It was motile by hanging drop method. Routine biochemical tests were done and it was catalase positive, oxidase positive, indole not produced, urea not hydrolyzed, citrate not utilized, TSI medium showed both slant, and butt alkaline without H2S production. There was no hemolysis on blood agar culture plate. Further identification was done by VITEK-2 (fully automated identification system) using GN-25 card (bioMerieux, Marcy l'Etoile France). It was identified as C. testosteroni with 98% probability. There was no growth in anaerobic blood culture bottle even after 7 days of anaerobic incubation. Urine sample was also sent to the microbiology department for culture and sensitivity. It was processed on Cysteine lactose electrolyte deficient media and similar colony morphology was seen as on MacConkey and blood agar. Further identification was done by VITEK-2 using GN-25 card, and again it was identified as C. testosteroni with 97% probability. The isolation of same bacteria from both the clinical samples (blood and urine) confirmed its pathogenic role. The isolate was found to be sensitive to gentamicin, amikacin, imipenem, meropenem, ciprofloxacin, tigecycline, cotrimoxazole, cefuroxime, colistin, and resistant to piperacilline-tazobactam. Therapy was changed to gentamicin 4 mg/kg/dose daily and imipenem 25 mg/kg/dose 8 hourly for 10 days. The patient responded well to antibiotic therapy. Fever was subsided 3rd day after starting therapy. Blood sample was taken again for culture, 7 days after completion of antibiotic therapy, and it was negative. Urine sample was also collected with complete aseptic precaution for culture and there was no growth. The patient is doing well during follow-up.
Figure 1

Nonlactose fermenting colony of Comamonas testosteroni on MacConkey agar

Nonlactose fermenting colony of Comamonas testosteroni on MacConkey agar

Discussion

C. testosteroni is a widely distributed aerobic Gram-negative bacillus which is rarely seen as a human pathogen. Now a day, this bacterium has been identified in various hospital devices; however, it has not been recognized as a component of the endogenous human microflora. Because this bacterium has been more frequently encountered (till now around 36 cases), we thought that this case would be beneficial for clinicians and laboratory physicians in their diagnosis and clinical approach[4] [Table 1]. Majority of the infections are community-acquired rather than nosocomial.[56] Most of the previously reported patients were immunodeficient due to malignancy, chronic liver disease, and end-stage renal disease taking hemodialysis.[78] However, in our case, the patient was immunocompetent based on the results of their previous reports. C. testosteroni is the most common species among its various species causing human infection and majority of the patients were survived. Till now around 16 cases of C. testosteroni bacteremia reported in medical literature, and out of which majority were male but our case was a female patient. Most of the patient responded well to appropriate antimicrobial therapy. Comamonas species are usually susceptible to aminoglycosides, fluoroquinolones, carbapenems, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and cephalosporins.
Table 1

Comamonas testosteroni infections in the medical literature

Age/sexDiagnosisSampleAntibiotic treatmentResultReferences
54 years/femaleCatheter related infectionBloodCefepime, ciprofloxacinRecoveredAbraham et al.
50 years/maleCholesteatomaCSFMeropenemRecoveredArda et al.
31 years/femaleBacteremiaBone marrowKanamycin, tetracyclineRecoveredAtkinson et al.
31 years/maleAppendicitisAbscessCefoxitinRecoveredBarbaro et al.
24 years/femaleIVDACSFMoxalactam and nafcillinRecoveredBarbaro et al.
59 year/femaleAlcoholic cirrhosisPeritoneal fluidCefoxitinRecoveredBarbaro et al.
11 years/maleAppendicitisPeritoneal fluidAmpicillin, clindamycin, tobramycinRecoveredBarbaro et al.
12 years/femaleAppendicitisPeritoneal fluidCefoxitinRecoveredBarbaro et al.
21 years/femaleAppendicitisPeritoneal fluidCefoxitinRecoveredBarbaro et al.
NB/StillbirthMaternal IVDAUmblical cord-blood-StillbirthBarbaro et al.
84 years/femaleCHFUrineAmpicillinRecoveredBarbaro et al.
24 years/maleAppendicitisPeritoneal fluidCefoxitinRecoveredBarbaro et al.
Female/NBMaternal IVDABloodAmpicillin, amikacinDeadBarbaro et al.
49 years/maleInfective endocarditisBlood and mitral valveCefepime, gentamicinRecoveredCooper et al.
No dataAIDSRespiratory secretionsCeftazidimeRecoveredFranzetti et al.
22 years/maleAppendicitisPeritoneal fluid, bloodCefazolinRecoveredGul M et al.
75 years/femaleCatheter related infectionBlood and CVCCeftazidime, gentamicinRecoveredLe Moal et al.
54 years/maleCellulitisBloodOxacillin, ciprofloxacinRecoveredTsui et al.
73 years/maleIntra-abdominal infection and hepatocellular carcinomaBloodGentamicin, levofloxacinRecoveredTsui et al.
82 years/femaleEndophthalmitisVitreous biopsy-RecoveredReddy et al.
83 years/maleBacteremiaBloodAmikacin, piperacillin-tazobactamRecoveredKatircioglu et al.
63 years/femaleCatheter related bloodstream infection in patient on hemodialysisBloodVancomycin, ceftriaxoneDeadNseir et al.
10 years/maleBacteremiaBloodCiprofloxacin, amikacinRecoveredFarshad et al.
19 years/femaleBacteremiaBloodCiprofloxacin, vancomycin, imipenemRecoveredFarshad et al.
51 years/maleEndocarditisAortic valveCiprofloxacinRecoveredArzu Duran et al.
80 years/femaleBacteremiaBloodCefazolin and doripenemRecoveredOrsini Jose et al.
42 years/femaleSeptic shockBlood and urineCeftazidime and levofloxacinRecoveredHyun Jung Kim et al.
65 years/femaleGastroenteritisStoolCiprofloxacin and probioticsRecoveredShaika Farooq et al.
46 years/femaleBacteremiaBlood and urineGentamicin and imipenemRecoveredPresent case

CVC=Central venous catheter, CSF=Cerebrospinal fluid, CHF=Congestive heart failure, AIDS=Acquired immune deficiency syndrome, IVDA=Intravenous drug abuse, NB=Newborn

Comamonas testosteroni infections in the medical literature CVC=Central venous catheter, CSF=Cerebrospinal fluid, CHF=Congestive heart failure, AIDS=Acquired immune deficiency syndrome, IVDA=Intravenous drug abuse, NB=Newborn Until 1987, C. testosteroni has only rarely been associated to human infections. In the late 1980s, researchers reported 18 unrelated cases during a research >3 years suggesting that this species might be missed if not carefully identified by clinical microbiology laboratories. Although the pathogenic potential of C. testosteroni has not been well studied, it is usually considered a commensal. Because C. testosteroni can be isolated from fresh water, it seems likely that wound infection could occur after contact with contaminated water. Intra-abdominal infections are the most common infections caused by C. testosteroni. Bacterial translocation from gastrointestinal tract seems to play an important role in the pathogenesis caused by Comamonas species.[9] The high genetic pliability of Comamonas species, as well as their inherent ability as an environmental pathogen to survive in various ecological niches, makes it an appropriate candidate to cause mild but persistent infections, particularly in an individual with predisposing conditions. In our case, there was no obvious source of infection. The patient did not have central venous catheters, USG abdomen did not show any mass. The patient did not have any immunological deficiency such as malignancy and diabetes mellitus. HIV status was negative. All these factors might have played a role as predisposing factors. In the present case, the patient belongs to rural area so the source of infection might be the contaminated food and water, although this hypothesis cannot be proven. It is only presumed as there was no proven source of infection. Polymicrobial bacteremia involving C. testosteroni have been reported in association with Streptococcus parasanguis, Streptococcus agalactiae, Ralstonia pickettii, and Bacteroides fragilis.[10] C. testosteroni is able to survive in the hospital environment for a long time, and majority of infections are community acquired. It is anticipated that nosocomial infection related to this bacterium will increase over time as there is increase in long hospital stay with impaired immune system and long-term use of the intravenous catheter. Most of the laboratories are not well equipped to detect such atypical pathogens that can cause human infection in certain clinical settings. Therefore, automated identification system (VITEK-2) can help to identify such rare isolates. In this case report, we have highlighted an unusual cause of bloodstream infection caused by C. testosteroni. Comamonas species should be kept in mind as a rare cause of bacteremia. The main target to report such an unusual case is to sensitize clinicians and clinical microbiologists for bloodstream infections caused by such unusual pathogens. However, more research should be done to understand the pathogenicity, virulence mechanism, and increased antibiotic resistance of C. testosteroni.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

1.  Genes Encoding Microbial Acyl Coenzyme A Binding Protein/Diazepam-Binding Inhibitor Orthologs Are Rare in the Human Gut Microbiome and Show No Links to Obesity.

Authors:  Andrew Maltez Thomas; Francesco Asnicar; Guido Kroemer; Nicola Segata
Journal:  Appl Environ Microbiol       Date:  2021-05-26       Impact factor: 4.792

2.  Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis.

Authors:  Zena Chen; Xuqi Zheng; Xinyu Wu; Jialing Wu; Xiaomin Li; Qiujing Wei; Xi Zhang; Linkai Fang; Ou Jin; Jieruo Gu
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

3.  Culturomics revealed the bacterial constituents of the microbiota of a 10-year-old laboratory culture of planarian species S. mediterranea.

Authors:  Luis Johnson Kangale; Didier Raoult; Pierre-Edouard Fournier; Eric Ghigo
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

4.  Comamonas testosteroni bacteremia: A rare unusual pathogen detected in a burned patient: Case report and literature review.

Authors:  Ayham Sammoni; Ali Abdalah; Maen Al-Aissami
Journal:  Ann Med Surg (Lond)       Date:  2022-02-11

5.  Changes in Gut Microbiota Composition Associated with the Presence of Enteric Protist Blastocystis in Captive Forest Musk Deer (Moschus Berezovskii).

Authors:  Lei Deng; Shanyu Chen; Wanyu Meng; Ziyao Zhou; Haifeng Liu; Zhijun Zhong; Hualin Fu; Liuhong Shen; Suizhong Cao; Kevin S W Tan; Guangneng Peng
Journal:  Microbiol Spectr       Date:  2022-06-23

6.  The Effect of Necrotic Enteritis Challenge on Production Performance, Cecal Microbiome, and Cecal Tonsil Transcriptome in Broilers.

Authors:  Gabriel Akerele; Walid G Al Hakeem; Jeferson Lourenco; Ramesh K Selvaraj
Journal:  Pathogens       Date:  2022-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.